Schedule 13G ownership disclosure
Amicus Therapeutics Inc
Security class unavailable · CUSIP: 03152W109
Event date: 2017-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 12,085,770
- Percent of class
- 7.1800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001425738-18-000009
- Form type
- SC 13G
- Filer
- AMICUS THERAPEUTICS, INC.
- CIK
- CIK 1178879
- Filed
- Feb 14, 2018
- Reporting period
- Dec 31, 2017
- Description
- Schedule 13G beneficial ownership